IOLCP Declares Interim Dividend of ₹1/Share, Sets Record Date for Feb 17
IOL Chemicals and Pharmaceuticals Limited announced its Q3 FY26 results. The company declared an interim dividend of ₹1 per share. The record date for the dividend is February 17, 2026. The financial results for the quarter and nine months ended December 31, 2025, were approved.
The interim dividend is a direct positive financial return to shareholders. The financial results, while routine, provide performance updates.
The declaration of an interim dividend and the approval of financial results are positive indicators for the company.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) announced its un-audited financial results for the quarter and nine months ended December 31, 2025. The Board of Directors, in their meeting held on February 11, 2026, approved the standalone and consolidated financial results.
In addition to the financial results, the Board declared an interim dividend of ₹1 per equity share (50%) for the Financial Year 2025-26. The record date for determining the entitlement of shareholders to this dividend has been fixed as February 17, 2026. The payment of the interim dividend will be made to eligible shareholders within 30 days of its declaration.
The company also reported an exceptional item of ₹11.21 crore, primarily arising from changes in the wage definition due to the notification of four Labour Codes by the Government of India. The financial results were subjected to a limited review by the statutory auditors, who issued an unmodified report. The meeting of the Board of Directors commenced at 1:15 PM and concluded at 3:00 PM.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.